HALO
Halozyme Therapeutics, Inc. · Healthcare
President and CEO Helen Torley sold $1.7M of Halozyme Therapeutics, Inc.
Sold$1,714,451
$57.15Price
30,000Shares
−4%Stake
What HALO did after the filing
- The stock from Fri, Aug 16 open, $59.06
- −3.1%
- S&P 500, same days
- +4.4%
Measured over 30 trading days, to the Sep 30 close.
Traded Tue, Aug 13. Filed Thu, Aug 15, 4:59 PM ET, after the close. Returns use the Aug 16 open and the Sep 30 close. Not investment advice.